Concepedia

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto, Wan‐Long Chuang, Chi-Yi Chen, Hyung Joon Kim, Aric J. Hui, Harry L.A. Janssen, Abhijit Chowdhury, Tak Yin Owen Tsang,

˜The œLancet. Gastroenterology & hepatology · 2016 · 458 citations · 29 references

DOI

Concepts

References

29

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano, Mohsen Naghavi, Kyle J Foreman et al. · The Lancet · 2012 · 14.3K citations · Full text

, , +16

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

Journal of Hepatology · 2012 · 2.9K citations · Full text

, , +17

AASLD guidelines for treatment of chronic hepatitis B

Norah A. Terrault, Natalie Bzowej, Kyong‐Mi Chang et al. · Hepatology · 2015 · 2K citations

, , +15

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin, Edward Gane, Nezam H. Afdhal et al. · The Lancet · 2012 · 1.8K citations

, , +16

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Ting‐Tsung Chang, Robert G. Gish, Robert de Man et al. · New England Journal of Medicine · 2006 · 1.4K citations · Full text

, , +10